OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The expansion of circulating IL-6 and IL-17-secreting follicular helper T cells is associated with neurological disabilities in neuromyelitis optica spectrum disorders
Clarice Monteiro, Gabriel Fernandes, Taissa M. Kasahara, et al.
Journal of Neuroimmunology (2019) Vol. 330, pp. 12-18
Closed Access | Times Cited: 22

Showing 22 citing articles:

Autoimmune Neuroinflammatory Diseases: Role of Interleukins
Abdul Waheed Khan, Mariya Farooq, Moon-Jung Hwang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7960-7960
Open Access | Times Cited: 34

NMOSD and MOGAD: an evolving disease spectrum
Akiyuki Uzawa, Frederike Cosima Oertel, Masahiro Mori, et al.
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 11

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
Alessandro Dinoto, Elia Sechi, Eoin P. Flanagan, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 23

STING Deficiency Promotes Th17-Like Tfh to Aggravate the Experimental Autoimmune Uveitis
Zhuang Li, Xiuxing Liu, Zuoyi Li, et al.
Investigative Ophthalmology & Visual Science (2025) Vol. 66, Iss. 3, pp. 8-8
Open Access

Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis
Miaomiao Hou, Yufeng Li, Lingling He, et al.
International Immunopharmacology (2019) Vol. 75, pp. 105793-105793
Closed Access | Times Cited: 32

The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab
Philippe Nicolas, Anne Ruiz, Álvaro Cobo‐Calvo, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 31

T follicular helper cells contribute to pathophysiology in a model of neuromyelitis optica spectrum disorders
Leung-Wah Yick, Oscar Ka-Fai, Ethel Yin-Ying Chan, et al.
JCI Insight (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 8

Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects.
Fereshte Ashtari, Reyhanehsadat Madanian, Vahid Shaygannejad, et al.
PubMed (2019) Vol. 11, Iss. 6, pp. 267-273
Closed Access | Times Cited: 25

Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives
Tzu‐Lun Huang, Jia-Kang Wang, Pei-Yao Chang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7908-7908
Open Access | Times Cited: 10

TLR-2 and TLR-4 agonists favor expansion of CD4+ T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders
Aleida Dias, Priscila M. Sacramento, Lana M. Lopes, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 34, pp. 66-76
Closed Access | Times Cited: 14

Interferon-γ controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder
Gabriel Arellano, Eileah Loda, Yanan Chen, et al.
Brain (2023) Vol. 147, Iss. 4, pp. 1344-1361
Open Access | Times Cited: 4

Moving beyond anti-aquaporin-4 antibodies: emerging biomarkers in the spectrum of neuromyelitis optica
Maria A. Rocca, Laura Cacciaguerra, Massimo Filippi
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 6, pp. 601-618
Closed Access | Times Cited: 10

Rituximab induces a transient fluctuation of peripheral and follicular helper T cells in neuromyelitis optica spectrum disorder
Zhenning Huang, Ye Liu, Xueting An, et al.
Journal of Neuroimmunology (2023) Vol. 382, pp. 578167-578167
Open Access | Times Cited: 3

Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder
Dean M. Wingerchuk, Brian G. Weinshenker, Dana McCormick, et al.
Journal of Managed Care & Specialty Pharmacy (2022) Vol. 28, Iss. 12-a Suppl, pp. S3-S27
Closed Access | Times Cited: 5

The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder
Zhila Maghbooli, Abdorreza Naser Moghadasi, Nasim Rezaeimanesh, et al.
BMC Neurology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 7

Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study
Laura Dresser, Widad Abou Chaar, Anthony T. Reder, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 74, pp. 104718-104718
Open Access | Times Cited: 2

Immunopathogenesis of acute disseminated encephalomyelitis
Nusrat Ahsan, Jonathan D. Santoro
Elsevier eBooks (2022), pp. 249-263
Closed Access | Times Cited: 1

The Possible Role of Interleukin-6 as a Regulator of Insulin Sensitivity in Patients With Neuromyelitis Optica Spectrum Disorder
Zhila Maghbooli, Abdorreza Naser Moghadasi, Nasim Rezaeimanesh, et al.
Research Square (Research Square) (2020)
Open Access

Page 1

Scroll to top